The RASSF6 tumor suppressor protein regulates apoptosis and the cell cycle via MDM2 protein and p53 protein

Journal of Biological Chemistry

Volumn 288, Issue 42, 2013, Pages 30320-30329

  Iwasa, Hiroaki ^a   Kudo, Takumi ^a   Maimaiti, Sainawaer ^a,b   Ikeda, Mitsunobu ^a   Maruyama, Junichi ^a   Nakagawa, Kentaro ^a   Hata, Yutaka ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b Department of Psychotherapy   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE; CELL-CYCLE ARREST; P53 PROTEIN; TUMOR SUPPRESSOR PROTEINS; WORK SUPPORT;

CELL DEATH;

PROTEINS;

DNA; ETOPOSIDE; PROTEIN MDM2; PROTEIN P53; PROTEIN RASSF3; PROTEIN RASSF6; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CARBOXY TERMINAL SEQUENCE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL STRAIN HCT116; DNA REPAIR; GENE TARGETING; HUMAN; HUMAN CELL; POLYPLOIDY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; UBIQUITINATION; ULTRAVIOLET SPECTROSCOPY; UPREGULATION;

APOPTOSIS; CHECKPOINT CONTROL; DNA DAMAGE; HIPPO PATHWAY; P53; RASSF; TUMOR SUPPRESSOR GENE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL LINE, TUMOR; DNA REPAIR; ETOPOSIDE; G1 PHASE CELL CYCLE CHECKPOINTS; HUMANS; MONOMERIC GTP-BINDING PROTEINS; PROTEIN BINDING; PROTEOLYSIS; PROTO-ONCOGENE PROTEINS C-MDM2; S PHASE CELL CYCLE CHECKPOINTS; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITINATION; ULTRAVIOLET RAYS; UP-REGULATION;

EID: 84886878688     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.507384     Document Type: Article

References (28)

1. Avruch, J., Xavier, R., Bardeesy, N., Zhang, X. F., Praskova, M., Zhou, D., and Xia, F. (2009) Rassf family of tumor suppressor polypeptides. J. Biol. Chem. 284, 11001-11005
2. Richter, A. M., Pfeifer, G. P., and Dammann, R. H. (2009) The RASSF proteins in cancer. From epigenetic silencing to functional characterization. Biochim. Biophys. Acta 1796, 114-128
3. Sherwood, V., Recino, A., Jeffries, A., Ward, A., and Chalmers, A. D. (2010) The N-terminal RASSF family. A new group of Ras-association- domaincontaining proteins, with emerging links to cancer formation. Biochem. J. 425, 303-311
4. Underhill-Day, N., Hill, V., and Latif, F. (2011) N-terminal RASSF family. RASSF7-RASSF10. Epigenetics 6, 284-292
5. Allen, N. P., Donninger, H., Vos, M. D., Eckfeld, K., Hesson, L., Gordon, L., Birrer, M. J., Latif, F., and Clark, G. J. (2007) RASSF6 is a novel member of the RASSF family of tumor suppressors. Oncogene 26, 6203-6211
6. Hesson, L. B., Dunwell, T. L., Cooper, W. N., Catchpoole, D., Brini, A. T., Chiaramonte, R., Griffiths, M., Chalmers, A. D., Maher, E. R., and Latif, F. (2009) The novel RASSF6 and RASSF10 candidate tumour suppressor genes are frequently epigenetically inactivated in childhood leukaemias. Mol. Cancer 8, 42
7. Wen, Y., Wang, Q., Zhou, C., Yan, D., Qiu, G., Yang, C., Tang, H., and Peng, Z. (2011) Decreased expression of RASSF6 is a novel independent prognostic marker of a worse outcome in gastric cancer patients after curative surgery. Ann. Surg. Oncol. 18, 3858-3867
8. Ikeda, M., Hirabayashi, S., Fujiwara, N., Mori, H., Kawata, A., Iida, J., Bao, Y., Sato, Y., Iida, T., Sugimura, H., and Hata, Y. (2007) Ras-association domain family protein 6 induces apoptosis via both caspase-dependent and caspase-independent pathways. Exp. Cell Res. 313, 1484-1495
9. Withanage, K., Nakagawa, K., Ikeda, M., Kurihara, H., Kudo, T., Yang, Z., Sakane, A., Sasaki, T., and Hata, Y. (2012) Expression of RASSF6 in kidney and the implication of RASSF6 and the Hippo pathway in the sorbitolinduced apoptosis in renal proximal tubular epithelial cells. J. Biochem. 152, 111-119
10. Pan, D. (2010) The Hippo signaling pathway in development and cancer. Dev. Cell 19, 491-505
11. Bao, Y., Hata, Y., Ikeda, M., and Withanage, K. (2011) Mammalian Hippo pathway. From development to cancer and beyond. J. Biochem. 149, 361-379
12. Zhao, B., Tumaneng, K., and Guan, K. L. (2011) The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal. Nat. Cell Biol. 13, 877-883
13. Ikeda, M., Kawata, A., Nishikawa, M., Tateishi, Y., Yamaguchi, M., Nakagawa, K., Hirabayashi, S., Bao, Y., Hidaka, S., Hirata, Y., and Hata, Y. (2009) Hippo pathway-dependent and -independent roles of RASSF6. Sci. Signal. 2, ra59
14. Song, M. S., Song, S. J., Kim, S. Y., Oh, H. J., and Lim, D. S. (2008) The tumour suppressor RASSF1A promotes MDM2 self-ubiquitination by disrupting the MDM2-DAXX-HAUSP complex. EMBO J. 27, 1863-1874
15. Calvisi, D. F., Donninger, H., Vos, M. D., Birrer, M. J., Gordon, L., Leaner, V., and Clark, G. J. (2009) NORE1A tumor suppressor candidate modulates p21CIP1 via p53. Cancer Res. 69, 4629-4637
16. Kudo, T., Ikeda, M., Nishikawa, M., Yang, Z., Ohno, K., Nakagawa, K., and Hata, Y. (2012) The RASSF3 candidate tumor suppressor induces apoptosis and G1-S cell-cycle arrest via p53. Cancer Res. 72, 2901-2911
17. Tommasi, S., Besaratinia, A., Wilczynski, S. P., and Pfeifer, G. P. (2011) Loss of Rassf1a enhances p53-mediated tumor predisposition and accelerates progression to aneuploidy. Oncogene 30, 690-700
18. Yee, K. S., Grochola, L., Hamilton, G., Grawenda, A., Bond, E. E., Taubert, H., Wurl, P., Bond, G. L., and O'Neill, E. (2012) ARASSF1A polymorphism restricts p53/p73 activation and associates with poor survival and accelerated age of onset of soft tissue sarcoma. Cancer Res. 72, 2206-2217
19. Matallanas, D., Romano, D., Yee, K., Meissl, K., Kucerova, L., Piazzolla, D., Baccarini, M., Vass, J. K., Kolch, W., and O'Neill, E. (2007) RASSF1A elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the p73 tumor suppressor protein. Mol. Cell 27, 962-975
20. Donninger, H., Vos, M. D., and Clark, G. J. (2007) The RASSF1A tumor suppressor. J. Cell Sci. 120, 3163-3172
21. Hamilton, G., Yee, K. S., Scrace, S., and O'Neill, E. (2009) ATM regulates a RASSF1A-dependent DNA damage response. Curr. Biol. 19, 2020-2025
22. Khokhlatchev, A., Rabizadeh, S., Xavier, R., Nedwidek, M., Chen, T., Zhang, X. F., Seed, B., and Avruch, J. (2002) Identification of a novel Rasregulated proapoptotic pathway. Curr. Biol. 12, 253-265
23. Matallanas, D., Romano, D., Al-Mulla, F., O'Neill, E., Al-Ali, W., Crespo, P., Doyle, B., Nixon, C., Sansom, O., Drosten, M., Barbacid, M., and Kolch, W. (2011) Mutant K-Ras activation of the proapoptotic MST2 pathway is antagonized by wild-type K-Ras. Mol. Cell 44, 893-906
24. Praskova, M., Khoklatchev, A., Ortiz-Vega, S., and Avruch, J. (2004) Regulation of the MST1 kinase by autophosphorylation, by the growth inhibitory proteins, RASSF1 and NORE1, and by Ras. Biochem. J. 381, 453-462
25. Guo, C., Tommasi, S., Liu, L., Yee, J. K., Dammann, R., and Pfeifer, G. P. (2007) RASSF1A is part of a complex similar to the Drosophila Hippo/ Salvador/Lats tumor-suppressor network. Curr. Biol. 17, 700-705
26. Cooper, W. N., Hesson, L. B., Matallanas, D., Dallol, A., von Kriegsheim, A., Ward, R., Kolch, W., and Latif, F. (2009) RASSF2 associates with and stabilizes the proapoptotic kinase MST2. Oncogene 28, 2988-2998
27. Song, H., Oh, S., Oh, H. J., and Lim, D. S. (2010) Role of the tumor suppressor RASSF2 in regulation of MST1 kinase activity. Biochem. Biophys. Res. Commun. 391, 969-973
28. Chan, J. J., Flatters, D., Rodrigues-Lima, F., Yan, J., Thalassinos, K., and Katan, M. (2013) Comparative analysis of interactions of RASSF1-10. Adv. Biol. Regul. 53, 190-201